Probucol-bile acid based nanoparticles protect auditory cells from oxidative stress: an in vitro study
- PMID: 38469721
- DOI: 10.4155/tde-2023-0099
Probucol-bile acid based nanoparticles protect auditory cells from oxidative stress: an in vitro study
Abstract
Aim: Excessive free radicals contribute to oxidative stress and mitochondrial dysfunction in sensorineural hearing loss (SNHL). The antioxidant probucol holds promise, but its limited bioavailability and inner ear barriers hinder effective SNHL treatment. Methodology: We addressed this by developing probucol-loaded nanoparticles with polymers and lithocholic acid and tested them on House Ear Institute-Organ of Corti cells. Results: Probucol-based nanoparticles effectively reduced oxidative stress-induced apoptosis, enhanced cellular viability, improved probucol uptake and promoted mitochondrial function. Additionally, they demonstrated the capacity to reduce reactive oxygen species through the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 pathway. Conclusion: This innovative nanoparticle system holds the potential to prevent oxidative stress-related hearing impairment, providing an effective solution for SNHL.
Keywords: bile acid; hearing impairment; nanoparticles; oxidative stress; probucol.
Plain language summary
Hearing loss affects millions of people worldwide, and its prevalence is expected to double by 2050. Current treatments have limitations, pushing researchers to explore new options. Oxidative stress is a key player in hearing loss and is known to damage inner ear hair cells. While antioxidants, known for their protective effects, hold promise, delivering them effectively to the inner ear is challenging. Scientists have been testing nanoparticles loaded with the antioxidant probucol to fight hearing loss. In this study, these particles protected inner ear cells in cell studies, offering potential hope for preventing hearing problems. This research is a significant step toward finding better treatments for hearing loss.
Similar articles
-
Pharmaceutical characterization of probucol bile acid-lithocholic acid nanoparticles to prevent chronic hearing related and similar cellular oxidative stress pathologies.Nanomedicine (Lond). 2023 May;18(12):923-940. doi: 10.2217/nnm-2023-0092. Epub 2023 Aug 2. Nanomedicine (Lond). 2023. PMID: 37529927
-
Probucol-bile acid nanoparticles: a novel approach and promising solution to prevent cellular oxidative stress in sensorineural hearing loss.J Drug Target. 2024 Aug;32(7):737-755. doi: 10.1080/1061186X.2024.2349111. Epub 2024 Jun 21. J Drug Target. 2024. PMID: 38758361 Review.
-
Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss.Eur J Pharm Biopharm. 2024 Sep;202:114393. doi: 10.1016/j.ejpb.2024.114393. Epub 2024 Jul 9. Eur J Pharm Biopharm. 2024. PMID: 38992481 Review.
-
Polymer-Based Nanoparticles with Probucol and Lithocholic Acid: A Novel Therapeutic Approach for Oxidative Stress-Induced Retinopathies.Mol Pharm. 2024 Jul 1;21(7):3566-3576. doi: 10.1021/acs.molpharmaceut.4c00269. Epub 2024 Jun 20. Mol Pharm. 2024. PMID: 38899552
-
Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.Adv Drug Deliv Rev. 2017 Jan 1;108:2-12. doi: 10.1016/j.addr.2016.01.004. Epub 2016 Jan 12. Adv Drug Deliv Rev. 2017. PMID: 26796230 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources